A multi-institutional review of endovenous thermal ablation of the saphenous vein finds male sex and use of anticoagulation are predictors of long-term failure.


Journal

Phlebology
ISSN: 1758-1125
Titre abrégé: Phlebology
Pays: England
ID NLM: 9012921

Informations de publication

Date de publication:
May 2021
Historique:
pubmed: 13 11 2020
medline: 1 9 2021
entrez: 12 11 2020
Statut: ppublish

Résumé

To review long-term outcomes and saphenous vein (SV) occlusion rate after endovenous ablation (EVA) for symptomatic varicose veins. A review of our EVA database (1998-2018) with at least 3-years of clinical and sonographic follow-up. The primary end point was SV closure rate. 542 limbs were evaluated. 358 limbs had radiofrequency and 323 limbs had laser ablations; 542 great saphenous veins (GSV), 106 small saphenous veins (SSV) and 33 anterior accessory saphenous veins (AASV) were treated. Follow-up was 5.6 ± 2.3 years; 508 (74.6%) veins were occluded, 53 (7.8%) partially occluded and 120 (17.6%) were patent. On multivariable Cox regression analysis, male sex (HR 1.6, 95% CI [0.46-018], p = 0.012) and use anticoagulation (HR 2.0, 95% CI [0.69-0.34], p = 0.044) were predictors of long-term failure. On Kaplan-Meier curve, we had an 86.3% occlusion rate. Our experience revealed a 5-year closure rate of 86.3%. Ablations have satisfactory occlusion rate.

Sections du résumé

BACKGROUND BACKGROUND
To review long-term outcomes and saphenous vein (SV) occlusion rate after endovenous ablation (EVA) for symptomatic varicose veins.
METHODS METHODS
A review of our EVA database (1998-2018) with at least 3-years of clinical and sonographic follow-up. The primary end point was SV closure rate.
RESULTS RESULTS
542 limbs were evaluated. 358 limbs had radiofrequency and 323 limbs had laser ablations; 542 great saphenous veins (GSV), 106 small saphenous veins (SSV) and 33 anterior accessory saphenous veins (AASV) were treated. Follow-up was 5.6 ± 2.3 years; 508 (74.6%) veins were occluded, 53 (7.8%) partially occluded and 120 (17.6%) were patent. On multivariable Cox regression analysis, male sex (HR 1.6, 95% CI [0.46-018], p = 0.012) and use anticoagulation (HR 2.0, 95% CI [0.69-0.34], p = 0.044) were predictors of long-term failure. On Kaplan-Meier curve, we had an 86.3% occlusion rate.
CONCLUSION CONCLUSIONS
Our experience revealed a 5-year closure rate of 86.3%. Ablations have satisfactory occlusion rate.

Identifiants

pubmed: 33176592
doi: 10.1177/0268355520972923
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

283-289

Auteurs

Young Erben (Y)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL, USA.

Isabel Vasquez (I)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL, USA.

Yupeng Li (Y)

Department of Political Science and Economics, Rowan University, Glassboro, NJ, USA.

Peter Gloviczki (P)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA.

Manju Kalra (M)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA.

Gustavo Oderich (G)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA.

Randall R De Martino (RR)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA.

Haraldur Bjarnason (H)

Division of Vascular and Interventional Radiology, Mayo Clinic, Rochester, MN, USA.

Melissa J Neisen (MJ)

Division of Vascular and Interventional Radiology, Mayo Clinic, Rochester, MN, USA.

January F Moore (JF)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL, USA.

Joao A Da Rocha-Franco (JA)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL, USA.

Maria C Sanchez-Valenzuela (MC)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL, USA.

Gregory Frey (G)

Division of Vascular and Interventional Radiology, Mayo Clinic, Jacksonville, FL, USA.

Beau Toskich (B)

Division of Vascular and Interventional Radiology, Mayo Clinic, Jacksonville, FL, USA.

Zlatko Devcic (Z)

Division of Vascular and Interventional Radiology, Mayo Clinic, Jacksonville, FL, USA.

Houssam Farres (H)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL, USA.

Warren A Oldenburg (WA)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL, USA.

Jessica Gomez-Perez (J)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL, USA.

Justin R Yarbrough (JR)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL, USA.

Michael Adalia (M)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL, USA.

William Stone (W)

Divsion of Vascular and Endovascular Surgery, Mayo Clinic, Phoenix, AZ, USA.

Andrew J Meltzer (AJ)

Divsion of Vascular and Endovascular Surgery, Mayo Clinic, Phoenix, AZ, USA.

Albert G Hakaim (AG)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH